Learn about the future of pharma exports with technology, data and sustainability transforming global trade and driving exports of pharma products from India.
India’s pharmaceutical exports reached $30.4 billion in FY 2025. Learn what’s driving this growth—FDF exports, global demand, affordable generic drugs, emerging markets, and more.
AstraZeneca launches Eculizumab in India, offering new hope for PNH and aHUS patients with the first approved anti-complement therapy.
Learn how to reduce the risk of heart attack naturally with the best heart health tips. Simple changes in lifestyle, diet and habits can protect your heart.
Learn how personalized medicine is transforming healthcare with tailored treatments, better outcomes and innovative solutions from S V Healthcare.
S V Healthcare is expanding into emerging pharma markets in 2025. Discover key opportunities, challenges, and strategies for success.
Biocon Biologics has received UK MHRA approval for denosumab biosimilars Vevzuo and Avefraxi, expanding its global biosimilar footprint in 2025.
India’s pharma exports grew by 9% in FY 2024-25, higher than the global average. Find out the key drivers, trends and future outlook in this pharma export report.
Discover how tariffs impact the pharma industry globally. Learn about global trade challenges and how S V Healthcare adapts to changing export scenarios.
